Ikaria Holdings, Inc.
Industry
- Medical Devices
- Monitoring Equipment & Devices
- Pharmaceuticals
- Drug Delivery
- Biotechnology
Other Names/Subsidiaries
- Ikaria Bioscience Pty Ltd
- INO Therapeutics, LLC
Latest on Ikaria Holdings, Inc.
The US FDA Center for Drug Evaluation and Research’s novel approvals class of 2022 is notable for the absence of very fast reviews – approvals that come within six months of submission, or at least tw
Bristol Myers Squibb Company ’s Sotyku and Mallinckrodt plc ’s Terlivez provided two different kinds of examples that the late summer doldrums that had afflicted the novel approvals at the US FDA are
Hematology and orphan or untreated diseases emerged as themes for the US Food and Drug Administration’s mid-June approvals and recent applications. Alnylam Pharmaceuticals Inc. demonstrated the grow
The US FDA’s high-profile approval of a broad, breakthrough-designated heart failure indication for Eli Lilly and Company / Boehringer Ingelheim GmbH ’s Jardiance was a ray of sunshine in a week domi